基本信息
浏览量:1
职业迁徙
个人简介
Summary
Professor Walters's principal interests are the Molecular and cellular function of the small intestine -- in particular how the development and differentiation of the mucosal epithelial cells affects nutrient transport. This include the effects of inflammatory diseases of the intestine causing malabsorption, such as coeliac disease and Crohn's disease, and the changes in gene expression during active disease and the repair process.
Recent research has resulted in a paradigm shift in the understanding of chronic Bile Acid Diarrhoea (also known as Bile Salt Malabsorption or Bile Acid Malabsorption). Rather than malabsorption, underproduction of the ileal hormone FGF19 results in excessive hepatic bile acid synthesis, exceeding the normal capacity for absorption. A review showed that about one-third of patients with IBS-D have BAD and this represents around 1% of the adult population.
FGF19 production in the ileum is stimulated by bile acids and this is deficient in patients with BAD. Blood levels of this hormone are low. Drugs known as FXR agonists (obeticholic acid is the first in class) are able to stimulate production of FGF19 and give symptomatic improvement.
Prof. Walters aims to increase the awareness of BAD and to develop new treatments that are well tolerated.
Professor Walters's principal interests are the Molecular and cellular function of the small intestine -- in particular how the development and differentiation of the mucosal epithelial cells affects nutrient transport. This include the effects of inflammatory diseases of the intestine causing malabsorption, such as coeliac disease and Crohn's disease, and the changes in gene expression during active disease and the repair process.
Recent research has resulted in a paradigm shift in the understanding of chronic Bile Acid Diarrhoea (also known as Bile Salt Malabsorption or Bile Acid Malabsorption). Rather than malabsorption, underproduction of the ileal hormone FGF19 results in excessive hepatic bile acid synthesis, exceeding the normal capacity for absorption. A review showed that about one-third of patients with IBS-D have BAD and this represents around 1% of the adult population.
FGF19 production in the ileum is stimulated by bile acids and this is deficient in patients with BAD. Blood levels of this hormone are low. Drugs known as FXR agonists (obeticholic acid is the first in class) are able to stimulate production of FGF19 and give symptomatic improvement.
Prof. Walters aims to increase the awareness of BAD and to develop new treatments that are well tolerated.
研究兴趣
论文共 171 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn